Crimson Advisors

Crimson Advisors is a private strategic financial consulting firm associated with Darlene Deptula-Hicks, a finance executive with extensive experience in life sciences. The firm appears to provide strategic finance, capital formation, commercialization, corporate strategy, and M&A advisory services rather than developing therapeutic products. Available evidence ties the business to advisory work for biotechnology and life sciences companies, but there is no indication that Crimson Advisors itself operates a drug development pipeline. As a result, it is best characterized as a life sciences-focused advisory firm rather than a biotech, pharma, or healthcare operating company.